NCT05733676

Brief Summary

Dental cavities are among the most frequent diseases that affect teeth, particularly in patients who are treated with braces due to the difficulty in maintaining good oral hygiene in the presence of the mouth appliances. The white spot lesion (WSL) is the first clinical sign of cavities that presents itself as a milky-white opacity when located on the front face of the tooth. The aim to manage these early lesions focuses on promoting natural remineralization and preventing further demineralization. Various materials have been introduced for management of WSLs including MI paste and MI paste combined with fluoride (MI paste plus). Recently, a new material called resin infiltration has been found to treat these lesions with high esthetic results and great performance. According to the few numbers of in-vivo studies investigating the effectiveness of remineralization products, the aim of the current study is to clinically compare the outcome of the resin-infiltration and etching + MI paste plus to stop and improve the appearance of the WSL on front teeth in patients after treatment with braces.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
May 2023Oct 2026

First Submitted

Initial submission to the registry

February 8, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 17, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

May 30, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

July 4, 2025

Status Verified

July 1, 2025

Enrollment Period

2.8 years

First QC Date

February 8, 2023

Last Update Submit

July 2, 2025

Conditions

Keywords

White spot lesioncariesarrestedorthodontic

Outcome Measures

Primary Outcomes (2)

  • Remineralization as assessed by the Enamel Decalcification Index (EDI) score with values 0-3 in each of the four tooth surfaces

    Enamel decalcification index (EDI) score with values 0-3 in each of the four facial zones including mesial, distal, gingival, and occlusal surfaces around the approximate location of the debonded bracket it will represent the decalcification level based on clinical visual assessment of the tooth. The values will be recorded at baseline, 3, 6, 12,18 months. Tooth surfaces completely covered by gingiva or bonding material will be excluded. International caries detection and assessment system (ICDAS) with values 0-6 will be assigned to each tooth surface around the orthodontic bracket.

    3 years

  • Satisfaction evaluation of the white spot lesion (WSL) as assessed by a Visual Analog Scale (VAS) from 0 mm no change to 100 mm completely changed

    Intraoral frontal views will be taken at, 3, 6,12 and 18 months after completion of orthodontic treatment. This digital photography will be calibrated following protocols to standardize magnification, shade, and color. The images will be cropped to include the 4 incisors. Two independent, blinded panels will rate the WSL change using a visual analog scale (VAS) from 0 mm no change to 100 mm completely changed. The order of the participants will be shuffled so the bias resulted from examiner bias will be eliminated. The median value of the VAS will be selected as the representation for the percentage of change.

    3 years

Study Arms (2)

Resin Infiltration

ACTIVE COMPARATOR

Resin infiltration of early intervention of caries lesion as a consequences of orthodontic treatment

Device: Resin infiltrationDevice: Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride

Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride

ACTIVE COMPARATOR

Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride early intervention of caries lesion as a consequences of orthodontic treatment

Device: Resin infiltrationDevice: Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - Fluoride

Interventions

Base line treatment of white spot lesions in smooth surface with Resin infiltration -Icon + etch, DMG, Germany.

Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - FluorideResin Infiltration

Base line treatment of white spot lesions in smooth surface with MI paste plus + etch , GC corporation, Germany, Europe

Casein Phosphopeptide (CPP) - Amorphous Calcium Phosphate (ACP) - FluorideResin Infiltration

Eligibility Criteria

Age12 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Individuals in the age range of 12-21 years who had undergone fixed orthodontic appliance therapy for a duration of 12-36 months.
  • Should have at least one white spot lesion on the labial surface of either maxillary or mandibular anterior teeth after debonding. Lesion visible with or without drying the lesion surface.
  • Patients with mild to moderate plaque accumulation. Fair oral hygiene. With a simplified Oral Hygiene Index of no more than 1.3-3.0

You may not qualify if:

  • Poor oral hygiene Simplified Oral Hygiene Index of 3.1-6.0 or more
  • Patients with hypoplasia or any developmental defects on the buccal of upper or lower incisors
  • Patients with any restorations on the buccal of upper or lower incisors
  • Patients that have presented WSL on the buccal of upper or lower incisors before orthodontic treatment was initiated.
  • Patients that have received any re-mineralizing agent other than regular toothpaste during the last three months
  • Patient with allergy to milk or any of their products
  • Patient with any medical / oral or mental condition
  • Patients or legal guardians that does not speak or read English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KAYE Edmonton Clinic

Edmonton, Alberta, T6G 1Z1, Canada

RECRUITING

Related Publications (38)

  • Teshome A, Muche A, Girma B. Prevalence of Dental Caries and Associated Factors in East Africa, 2000-2020: Systematic Review and Meta-Analysis. Front Public Health. 2021 Apr 29;9:645091. doi: 10.3389/fpubh.2021.645091. eCollection 2021.

  • Cochrane NJ, Saranathan S, Cai F, Cross KJ, Reynolds EC. Enamel subsurface lesion remineralisation with casein phosphopeptide stabilised solutions of calcium, phosphate and fluoride. Caries Res. 2008;42(2):88-97. doi: 10.1159/000113161. Epub 2008 Jan 15.

  • Iijima Y, Cai F, Shen P, Walker G, Reynolds C, Reynolds EC. Acid resistance of enamel subsurface lesions remineralized by a sugar-free chewing gum containing casein phosphopeptide-amorphous calcium phosphate. Caries Res. 2004 Nov-Dec;38(6):551-6. doi: 10.1159/000080585.

  • Cai F, Manton DJ, Shen P, Walker GD, Cross KJ, Yuan Y, Reynolds C, Reynolds EC. Effect of addition of citric acid and casein phosphopeptide-amorphous calcium phosphate to a sugar-free chewing gum on enamel remineralization in situ. Caries Res. 2007;41(5):377-83. doi: 10.1159/000104796.

  • Huang GJ, Roloff-Chiang B, Mills BE, Shalchi S, Spiekerman C, Korpak AM, Starrett JL, Greenlee GM, Drangsholt RJ, Matunas JC. Effectiveness of MI Paste Plus and PreviDent fluoride varnish for treatment of white spot lesions: a randomized controlled trial. Am J Orthod Dentofacial Orthop. 2013 Jan;143(1):31-41. doi: 10.1016/j.ajodo.2012.09.007.

  • Rechmann P, Bekmezian S, Rechmann BMT, Chaffee BW, Featherstone JDB. MI Varnish and MI Paste Plus in a caries prevention and remineralization study: a randomized controlled trial. Clin Oral Investig. 2018 Jul;22(6):2229-2239. doi: 10.1007/s00784-017-2314-9. Epub 2018 Jan 4.

  • Kielbassa AM, Muller J, Gernhardt CR. Closing the gap between oral hygiene and minimally invasive dentistry: a review on the resin infiltration technique of incipient (proximal) enamel lesions. Quintessence Int. 2009 Sep;40(8):663-81.

  • Askar H, Schwendicke F, Lausch J, Meyer-Lueckel H, Paris S. Modified resin infiltration of non-, micro- and cavitated proximal caries lesions in vitro. J Dent. 2018 Jul;74:56-60. doi: 10.1016/j.jdent.2018.03.010. Epub 2018 May 16.

  • Mazur M, Westland S, Guerra F, Corridore D, Vichi M, Maruotti A, Nardi GM, Ottolenghi L. Objective and subjective aesthetic performance of icon(R) treatment for enamel hypomineralization lesions in young adolescents: A retrospective single center study. J Dent. 2018 Jan;68:104-108. doi: 10.1016/j.jdent.2017.11.001. Epub 2017 Nov 28.

  • Paris S, Meyer-Lueckel H. Inhibition of caries progression by resin infiltration in situ. Caries Res. 2010;44(1):47-54. doi: 10.1159/000275917. Epub 2010 Jan 16.

  • Chen M, Li JZ, Zuo QL, Liu C, Jiang H, Du MQ. Accelerated aging effects on color, microhardness and microstructure of ICON resin infiltration. Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7722-7731. doi: 10.26355/eurrev_201909_18981.

  • Walsh T, Worthington HV, Glenny AM, Appelbe P, Marinho VC, Shi X. Fluoride toothpastes of different concentrations for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007868. doi: 10.1002/14651858.CD007868.pub2.

  • Maheswari SU, Raja J, Kumar A, Seelan RG. Caries management by risk assessment: A review on current strategies for caries prevention and management. J Pharm Bioallied Sci. 2015 Aug;7(Suppl 2):S320-4. doi: 10.4103/0975-7406.163436.

  • Richter AE, Arruda AO, Peters MC, Sohn W. Incidence of caries lesions among patients treated with comprehensive orthodontics. Am J Orthod Dentofacial Orthop. 2011 May;139(5):657-64. doi: 10.1016/j.ajodo.2009.06.037.

  • Cruz CL, Edelstein BL. Linking orthodontic treatment and caries management for high-risk adolescents. Am J Orthod Dentofacial Orthop. 2016 Apr;149(4):441-2. doi: 10.1016/j.ajodo.2015.12.007. No abstract available.

  • Hagg U, Kaveewatcharanont P, Samaranayake YH, Samaranayake LP. The effect of fixed orthodontic appliances on the oral carriage of Candida species and Enterobacteriaceae. Eur J Orthod. 2004 Dec;26(6):623-9. doi: 10.1093/ejo/26.6.623.

  • Choi YY, Lee DY, Kim YJ. Colorimetric evaluation of white spot lesions following external bleaching with fluoridation: An in-vitro study. Korean J Orthod. 2018 Nov;48(6):377-383. doi: 10.4041/kjod.2018.48.6.377. Epub 2018 Sep 14.

  • Brochner A, Christensen C, Kristensen B, Tranaeus S, Karlsson L, Sonnesen L, Twetman S. Treatment of post-orthodontic white spot lesions with casein phosphopeptide-stabilised amorphous calcium phosphate. Clin Oral Investig. 2011 Jun;15(3):369-73. doi: 10.1007/s00784-010-0401-2. Epub 2010 Apr 10.

  • Reynolds EC. Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions. J Dent Res. 1997 Sep;76(9):1587-95. doi: 10.1177/00220345970760091101.

  • Oshiro M, Yamaguchi K, Takamizawa T, Inage H, Watanabe T, Irokawa A, Ando S, Miyazaki M. Effect of CPP-ACP paste on tooth mineralization: an FE-SEM study. J Oral Sci. 2007 Jun;49(2):115-20. doi: 10.2334/josnusd.49.115.

  • Kumar VL, Itthagarun A, King NM. The effect of casein phosphopeptide-amorphous calcium phosphate on remineralization of artificial caries-like lesions: an in vitro study. Aust Dent J. 2008 Mar;53(1):34-40. doi: 10.1111/j.1834-7819.2007.00006.x.

  • Reynolds EC, Cai F, Shen P, Walker GD. Retention in plaque and remineralization of enamel lesions by various forms of calcium in a mouthrinse or sugar-free chewing gum. J Dent Res. 2003 Mar;82(3):206-11. doi: 10.1177/154405910308200311.

  • Reynolds EC, Cai F, Cochrane NJ, Shen P, Walker GD, Morgan MV, Reynolds C. Fluoride and casein phosphopeptide-amorphous calcium phosphate. J Dent Res. 2008 Apr;87(4):344-8. doi: 10.1177/154405910808700420.

  • Shen P, Cai F, Nowicki A, Vincent J, Reynolds EC. Remineralization of enamel subsurface lesions by sugar-free chewing gum containing casein phosphopeptide-amorphous calcium phosphate. J Dent Res. 2001 Dec;80(12):2066-70. doi: 10.1177/00220345010800120801.

  • Manton DJ, Walker GD, Cai F, Cochrane NJ, Shen P, Reynolds EC. Remineralization of enamel subsurface lesions in situ by the use of three commercially available sugar-free gums. Int J Paediatr Dent. 2008 Jul;18(4):284-90. doi: 10.1111/j.1365-263X.2008.00920.x. Epub 2008 Apr 23.

  • Cai F, Shen P, Morgan MV, Reynolds EC. Remineralization of enamel subsurface lesions in situ by sugar-free lozenges containing casein phosphopeptide-amorphous calcium phosphate. Aust Dent J. 2003 Dec;48(4):240-3. doi: 10.1111/j.1834-7819.2003.tb00037.x.

  • Cochrane NJ, Shen P, Byrne SJ, Walker GD, Adams GG, Yuan Y, Reynolds C, Hoffmann B, Dashper SG, Reynolds EC. Remineralisation by chewing sugar-free gums in a randomised, controlled in situ trial including dietary intake and gauze to promote plaque formation. Caries Res. 2012;46(2):147-55. doi: 10.1159/000337240. Epub 2012 Apr 5.

  • Akin M, Basciftci FA. Can white spot lesions be treated effectively? Angle Orthod. 2012 Sep;82(5):770-5. doi: 10.2319/090711.578.1. Epub 2012 Feb 23.

  • Andersson A, Skold-Larsson K, Hallgren A, Petersson LG, Twetman S. Effect of a dental cream containing amorphous cream phosphate complexes on white spot lesion regression assessed by laser fluorescence. Oral Health Prev Dent. 2007;5(3):229-33.

  • Bailey DL, Adams GG, Tsao CE, Hyslop A, Escobar K, Manton DJ, Reynolds EC, Morgan MV. Regression of post-orthodontic lesions by a remineralizing cream. J Dent Res. 2009 Dec;88(12):1148-53. doi: 10.1177/0022034509347168. Epub 2009 Nov 3.

  • Wang JX, Yan Y, Wang XJ. Clinical evaluation of remineralization potential of casein phosphopeptide amorphous calcium phosphate nanocomplexes for enamel decalcification in orthodontics. Chin Med J (Engl). 2012 Nov;125(22):4018-21.

  • Singh S, Singh SP, Goyal A, Utreja AK, Jena AK. Effects of various remineralizing agents on the outcome of post-orthodontic white spot lesions (WSLs): a clinical trial. Prog Orthod. 2016 Dec;17(1):25. doi: 10.1186/s40510-016-0138-9. Epub 2016 Aug 2.

  • Beerens MW, van der Veen MH, van Beek H, ten Cate JM. Effects of casein phosphopeptide amorphous calcium fluoride phosphate paste on white spot lesions and dental plaque after orthodontic treatment: a 3-month follow-up. Eur J Oral Sci. 2010 Dec;118(6):610-7. doi: 10.1111/j.1600-0722.2010.00780.x.

  • Sabokseir A, Golkari A, Sheiham A. Distinguishing between enamel fluorosis and other enamel defects in permanent teeth of children. PeerJ. 2016 Feb 25;4:e1745. doi: 10.7717/peerj.1745. eCollection 2016.

  • Paris S, Hopfenmuller W, Meyer-Lueckel H. Resin infiltration of caries lesions: an efficacy randomized trial. J Dent Res. 2010 Aug;89(8):823-6. doi: 10.1177/0022034510369289. Epub 2010 May 26.

  • Senestraro SV, Crowe JJ, Wang M, Vo A, Huang G, Ferracane J, Covell DA Jr. Minimally invasive resin infiltration of arrested white-spot lesions: a randomized clinical trial. J Am Dent Assoc. 2013 Sep;144(9):997-1005. doi: 10.14219/jada.archive.2013.0225.

  • Bagher SM, Hegazi FM, Finkelman M, Ramesh A, Gowharji N, Swee G, Felemban O, Loo CY. Radiographic Effectiveness of Resin Infiltration in Arresting Incipient Proximal Enamel Lesions in Primary Molars. Pediatr Dent. 2018 May 15;40(3):195-200.

  • Giray FE, Durhan MA, Haznedaroglu E, Durmus B, Kalyoncu IO, Tanboga I. Resin infiltration technique and fluoride varnish on white spot lesions in children: Preliminary findings of a randomized clinical trial. Niger J Clin Pract. 2018 Dec;21(12):1564-1569. doi: 10.4103/njcp.njcp_209_18.

Related Links

MeSH Terms

Conditions

Heart Arrest

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Ida M Kornerup, DMD, MEd

    University of Alberta

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ida M Kornerup, DMD, MEd

CONTACT

Nancy Abdelhay, DMD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double, Participant and Outcomes Assessor
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The selected samples will be randomly allocated to two groups according to treatment received. Group I- Resin infiltration -Icon + etch, DMG, Germany. Group II- MI paste plus +etch , GC corporation, Germany, Europe,
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2023

First Posted

February 17, 2023

Study Start

May 30, 2023

Primary Completion

March 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

July 4, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations